Lysergic Acid Diethylamide Tartrate
Phase 2Small molecule
Lysergic Acid Diethylamide Tartrate is one of 5 small molecule programs targeting Basic Science. It is currently in Phase 2.
2
Indications
2
Total Trials
2
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
5 competitors in Palliative Care
#DrugCompanyPhaseTrials
1Psilocybin
COMPASS PathwaysPhase 2
Lysergic Acid Diethylamide Tartrate
RRigshospitalet, Denmark
Phase 2
Fscbd Cannabidiol
UUniversity of Colorado, Boulder
Phase 2
Bscbd Cannabidiol
UUniversity of Colorado, Boulder
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- RRigshospitalet, Denmark